Literature DB >> 20636863

In-vitro transdermal penetration of cytarabine and its N4-alkylamide derivatives.

Lesetja J Legoabe1, Jaco C Breytenbach, David D N'Da, J Wilma Breytenbach.   

Abstract

OBJECTIVES: The aim of this study was to synthesise and determine the transdermal penetration of cytarabine alkylamide derivatives and assess the correlation of flux with physicochemical properties.
METHODS: The alkylamide derivatives of cytarabine were synthesised by acylation at the N4-amino group by the mixed anhydride method. The in-vitro permeation studies were performed using the Franz diffusion cell methodology. Furthermore, partition coefficients (n-octanol-water) and aqueous solubility of the N4-alkylamide derivatives of cytarabine were determined in order to obtain information about their lipophilicity and hydrophilicity. KEY
FINDINGS: The N4-alkylamides of cytarabine (acetyl, butanoyl, hexanoyl, octanoyl, and decanoyl derivatives) showed decreased hydrophilicity and increased lipophilicity. The log D values of the alkylamides were higher than that of the parent compound and increased linearly as the alkyl chain lengthened. N4-hexanoyl-4-amino-1-[(2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl] pyrimidin-2-one) showed the highest median steady-state flux (J(ss)) of 89.0 nmol/cm(2) per h in the series, which shows a high statistical difference with the parent compound flux value (3.70 nmol/cm(2) per h).
CONCLUSIONS: The prodrug approach appears to be a promising strategy for the enhancement of transdermal penetration of cytarabine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636863     DOI: 10.1211/jpp.62.06.0012

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

Review 1.  Prodrug strategies for enhancing the percutaneous absorption of drugs.

Authors:  David D N'Da
Journal:  Molecules       Date:  2014-12-12       Impact factor: 4.411

2.  HuskinDB, a database for skin permeation of xenobiotics.

Authors:  Dmitri Stepanov; Steven Canipa; Gerhard Wolber
Journal:  Sci Data       Date:  2020-12-01       Impact factor: 6.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.